J L Cerfontaine
Overview
Explore the profile of J L Cerfontaine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ansseau M, von Frenckell R, Cerfontaine J, Papart P
Pharmacopsychiatry
. 1991 Jan;
24(1):8-12.
PMID: 1849286
PK 11195 is a selective ligand for the peripheral-type benzodiazepine binding sites which exhibits anti-conflict activity in animals. In a pilot open study, PK 11195 was administered to 10 psychiatric...
2.
Ansseau M, von Frenckell R, Cerfontaine J, Papart P, FRANCK G, Timsit-Berthier M, et al.
Br J Psychiatry
. 1988 Jul;
153:65-71.
PMID: 3224252
We measured the growth hormone (GH) response to clonidine (an alpha-2-adrenergic agonist) and to apomorphine (a dopaminergic agonist) in 15 major endogenous and 15 minor depressive in-patients matched for gender...
3.
Ansseau M, Bataille M, Bobon D, Cerfontaine J, Charles G, Couteaux F, et al.
Acta Psychiatr Belg
. 1988 Mar;
88(2):127-37.
PMID: 2905109
Ten psychiatrists have independently rated the clinical profile of fluoxetin (Prozac) at the daily dose of 20 mg according to a "Stars of Liège" model comprising three parameters of therapeutic...
4.
Ansseau M, von Frenckell R, Cerfontaine J, Papart P, FRANCK G, Timsit-Berthier M, et al.
Psychiatry Res
. 1987 Nov;
22(3):193-206.
PMID: 2829258
Several lines of evidence suggest catecholamine overactivity (noradrenergic and/or dopaminergic) in mania. We studied the growth hormone (GH) response to clonidine (an alpha-adrenergic agonist) and apomorphine (a dopaminergic agonist) in...
5.
DEMEY-PONSART E, Ansseau M, Sulon J, von Frenckell R, Cerfontaine J, Papart P, et al.
Biol Psychiatry
. 1987 Aug;
22(8):947-56.
PMID: 3607136
We assessed the 8:00 AM ratio of free cortisol/18-hydroxy-11-deoxycorticosterone (18-OH-DOC) in 56 endogenous depressive inpatients and in 22 normal volunteers. A ratio higher than 40 was associated with a diagnostic...
6.
Ansseau M, Cerfontaine J, von Frenckell R, Charles G, Papart P, FRANCK G
Encephale
. 1987 Mar;
13(2):67-72.
PMID: 3595512
The Newcastle index comprises 10 items (with a positive or negative score) the sum of which enables us to separate endogenous and neurotic depressive patients. We applied this index to...
7.
Ansseau M, Legros J, Mormont C, Cerfontaine J, Papart P, Geenen V, et al.
Psychoneuroendocrinology
. 1987 Jan;
12(3):231-6.
PMID: 3615752
A 55-year patient with obsessive-compulsive disorder showed clear improvement during 4 weeks of treatment with intranasal oxytocin compared to 4 weeks of intranasal placebo. This improvement was concurrent with the...
8.
Papart P, Ansseau M, Cerfontaine J, FRANCK G
Am J Psychiatry
. 1986 May;
143(5):684-5.
PMID: 3963267
No abstract available.
9.
Ansseau M, Diricq S, Bataille M, Breulet M, Cerfontaine J, Collard J, et al.
Acta Psychiatr Belg
. 1985 Sep;
85(5):644-61.
PMID: 4091024
In order to develop practical criteria to guide in the selection of antidepressant medication according to depressive symptomatology, we propose a graphical representation of the clinical activity of 24 antidepressants...
10.
Ansseau M, Doumont A, Cerfontaine J, Sulon J, DEMEY-PONSART E, Geenen V, et al.
Psychoneuroendocrinology
. 1985 Jan;
10(2):215-9.
PMID: 4034851
The performance of the dexamethasone suppression test (DST) in the diagnostic confirmation of endogenous depression was compared according to two times of blood collection--1600 hr on day 2 (usual sample)...